Rationale: Interstitial lung disease (ILD) represents a major challenge in systemic sclerosis (SSc),
but there are no precise, population-based data on its overall impact, limiting …

Objective Interstitial lung disease ( ILD ) in systemic sclerosis ( SS c) runs a highly variable
course, and prediction tools are highly desired. The aim of this study was to assess the …

Objectives To identify the predictive clinical characteristics and establish a prediction model
for the progression of mild interstitial lung disease (ILD) in patients with systemic sclerosis (…

Background : Primary cardiac affection is common and is a major cause of death in systemic
sclerosis (SSc), but there are knowledge gaps regarding the effect of cardiac dysfunction on …

Objectives Systemic sclerosis (SSc) is an auto-immune, multi organ disease marked by
severe gastrointestinal (GI) involvement and gut dysbiosis. Here, we aimed to determine the …

… Meier, H. Fretheim and AM. Hoffmann-Vold contributed to the acquisition and interpretation
of clinical data, and revised the manuscript. CT Nakas contributed to the statistical analysis …

The PERSEIDS study aimed to estimate incidence/prevalence of interstitial lung diseases (ILDs),
fibrosing interstitial lung diseases (F-ILDs), idiopathic pulmonary fibrosis (IPF), systemic …

Objective SSc is a severe, heterogeneous multi-organ disease where population-based
estimates on phenotypic spectrum, overall disease burden and societal impact are largely …

Objective The DETECT algorithm was developed for screening patients with SSc at high
risk of pulmonary arterial hypertension (PAH). We evaluated the impact of this algorithm in a …

Objective Systemic sclerosis (SSc) is a major cause of pulmonary arterial hypertension (PAH).
Murine models indicate key roles for chemokines CCL19 and CCL21 and their receptor …